The $10.1B surgical robotics and guidance market is rapidly growing, yet surgeons still rely on limited visualization, manual navigation, and subjective decision-making, increasing the risk of complications and reoperations. This company is transforming the operating room with an AI-powered surgical guidance system that integrates real-time 3D mapping, advanced tissue recognition, and precision-enhancing automation to improve accuracy, efficiency, and patient outcomes.
Unlike traditional laparoscopic and robotic systems that offer limited intraoperative insights, this next-generation platform provides real-time AI-driven support, allowing surgeons to visualize critical structures, anticipate complications, and enhance surgical precision—drastically reducing the need for revisions and optimizing healthcare costs. With exclusive IP, partnerships with top-tier medical institutions, and a first-mover advantage in AI-assisted surgery, the company is positioned to disrupt the field of minimally invasive procedures.
Currently raising $3M to finalize product development, conduct hospital testing, and secure FDA clearance, this is a rare opportunity to invest in the future of AI-driven surgical innovation.
View the deck through the link below. Some unique identifiers have been removed. For access to detailed materials, please reach to us or your point of contact, as full decks are only shared upon request to maintain confidentiality and exclusivity.
View Pitch Deck